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Abstract
Background: Escherichia coli O157:H7 is the most common serovar of enterohemorrhagic E. coli associated with
serious human disease outbreaks. Cattle are the main reservoir with E. coli O157:H7 inducing hemorrhagic enteritis
in persistent shedding beef cattle, however little is known about how this pathogen affects cattle health. Jejunal
Hemorrhage Syndrome (JHS) has unclear etiology but the pathology is similar to that described for E. coli O157:H7
challenged beef cattle suggestive that E. coli O157:H7 could be involved. There are no effective treatments for JHS
however new approaches to managing pathogen issues in livestock using prebiotics and probiotics are gaining
support. The first objective of the current study was to characterize pathogen colonization in hemorrhaged
jejunum of dairy cattle during natural JHS outbreaks. The second objective was to confirm the association of
mycotoxigenic fungi in feeds with the development of JHS and also to identify the presence of potential
mycotoxins. The third objective was to determine the impact of a prebiotic, Celmanax™, or probiotic, Dairyman’s
Choice™ paste, on the cytotoxicity associated with feed extracts in vitro. The fourth objective was to determine
the impact of a prebiotic or a probiotic on E. coli O157:H7 colonization of mucosal explants and a bovine colonic
cell line in vitro. The final objective was to determine if prebiotic and probiotic feed additives could modify the
symptoms that preceded JHS losses and the development of new JHS cases.
Findings: Dairy cattle developed JHS after consuming feed containing several types of mycotoxigenic fungi
including Fusarium culmorum, F. poae, F. verticillioides, F. sporotrichioides, Aspergillusflavus, Penicillium roqueforti,
P. crustosum, P. paneum and P. citrinum. Mixtures of Shiga toxin - producing Escherichia coli (STEC) colonized the
mucosa in the hemorrhaged tissues of the cattle and no other pathogen was identified. The STECs expressed Stx1
and Stx2, but more significantly, Stxs were also present in the blood clot blocking the jejunum. Mycotoxin analysis
of the corn crop confirmed the presence of fumonisin, NIV, ZEAR, DON, 15-ADON, 3-ADON, NEO, DAS, HT-2 and
T-2. Feed extracts were toxic to enterocytes and 0.1% Celmanax™ removed the cytotoxicity in vitro. There was no
effect of Dairyman’s Choice™ paste on feed-extract activity in vitro. Fumonisin, T-2, ZEAR and DON were toxic to
bovine cells and 0.1% Celmanax™ removed the cytotoxicity in vitro. Celmanax™ also directly decreased E. coli
O157:H7 colonization of mucosal explants and a colonic cell line in a dose-dependent manner. There was no effect
of Dairyman’s Choice™ paste on E. coli O157:H7 colonization in vitro. The inclusion of the prebiotic and probiotic
in the feed was associated with a decline in disease.
Conclusion: The current study confirmed an association between mycotoxigenic fungi in the feed and the
development of JHS in cattle. This association was further expanded to include mycotoxins in the feed and
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any medium, provided the original work is properly cited.mixtures of STECs colonizing the severely hemorrhaged tissues. Future studies should examine the extent of
involvement of the different STEC in the infection process. The prebiotic, Celmanax™, acted as an anti-adhesive for
STEC colonization and a mycotoxin binder in vitro. Future studies should determine the extent of involvement of
the prebiotic in altering disease.
Findings
Enterohemorrhagic Escherichia coli O157:H7 continues
to cause serious human disease outbreaks despite exten-
sive efforts at cattle processing facilities and feedlots to
reduce the transmission of disease [1-3]. Cattle are the
main reservoir for E. coli O157:H7 and like humans, the
majority of cattle resolve experimental-challenge infec-
tions on their own, while a few highly colonized indivi-
duals develop hemorrhagic enteritis [4]. It is currently
unclear why earlier E. coli O157:H7 challenge studies
did not report pathology, but we hypothesized that an
unknown factor such as feed or water quality may be
contributing to the development of disease. If E. coli
O157:H7 does cause disease in cattle, the most likely
candidates are diseases with unclear etiologies. Jejunal
Hemorrhage Syndrome (JHS) is an emerging hemorrha-
gic disease in dairy cattle that has been associated with
the presence of mycotoxigenic fungi in feed and the pre-
sence of Clostridiumperfringens type A in hemorrhaged
tissues, but there is some question as to whether this
pathogen actually plays a role [5]. Current treatments
for JHS are ineffective suggesting that a novel approach
to disease management must be undertaken. In mono-
gastric livestock, probiotic and prebiotic feed additives
mitigate pathogen issues in a number of ways including
enhancing the presence of beneficial bacteria in the
intestinal tract [6], improving mucosal barrier function
[7,8], increasing mucus production [9], inhibiting proin-
flammatory cytokines [10], enhancing the innate
immune response [11], binding pathogen toxins [12]
and interfering with colonization sites [8,13]. Very little
information is available concerning the benefits of pro-
biotics or prebiotics for managing pathogens in rumi-
nants. Probiotics do reduce E. coli O157:H7 shedding in
experimental-challenged immature calves [14] and adult
cattle [15]. To be effective as pathogen mitigation
agents, probiotics or prebiotics must escape fermenta-
tion in the rumen and digestion in the abomasum prior
to reaching any pathogen colonization sites in the
intestinal tract [13]. There is evidence to suggest that
prebiotics do survive the rumen environment [16] and
as such, these agents may be useful for addressing
pathogen issues and disease. The first objective of the
current study was to characterize the pathogens asso-
ciated with the hemorrhaged tissues during natural JHS
outbreaks in dairy cattle. The second objective was to
confirm the association of JHS development with the
presence of mycotoxigenic fungi in feed and to deter-
mine if their mycotoxins or cytotoxins were also pre-
sent. The third objective was to determine the impact of
a prebiotic, Celmanax™,a n dap r o b i o t i c ,D a i r y m a n ’s
Choice™ paste, on feed extract cytotoxicity in vitro. The
fourth objective was to determine the impact of the pre-
biotic and probiotic on E. coli O157:H7 colonization of
mucosal explants and a bovine colonic cell line in vitro.
The final objective was to monitor the impact of the
prebiotic and probiotic added to alleviate the reduction
in milk production on the neurological symptoms and
JHS development in dairy cattle during a natural JHS
outbreak.
Dairy production site 1 (PS1) with no history of JHS
A natural outbreak of JHS occurred in a commercial
dairy herd in December 2008 and January 2009 in
Southern Alberta, Canada. From 1 to 3 animals per
week developed disease symptoms and succumbed to
t h ed i s e a s ed e s p i t ea n t i b i o t i ci n t e r v e n t i o n s .E l e v e n
mature cattle developed JHS and an average of 10 other
animals per week had the neurological symptoms that
preceded the development of JHS. The initial diagnosis
was Acute Hemorrhagic Enteritis (AHE), however after
further examination of tissues, this was changed to JHS.
The principle difference in the diagnosis of these dis-
eases is the location and extent of hemorrhaging in the
intestinal tract. JHS presents with severe hemorrhaging
in the jejunum with a large blood clot blocking the
movement of digesta while AHE presents with hemor-
rhaging in several regions of the intestinal tract with
smaller blood clots. The producer reported symptoms
suggestive of a mycotoxicosis including lower milk pro-
duction, staggering, hindlimb paralysis, wasting and
higher than average mortality for the lactating cattle. To
alleviate the reduction in milk production, the producer
added a prebiotic (30 g) to the total mixed ration and a
single application of a prebiotic + probiotic (400 ml:10
g) delivered to cattle within 24 hr after calving. The pre-
biotic, Celmanax™ (Vi-COR
®,M a s o nC i t y ,I A ,U S A ) ,
consists of a non-living formulation of yeast cell walls or
mannan oligosaccharide (MOS) and yeast metabolites.
The probiotic, Dairyman’sC h o i c e ™ paste (Animal Pro-
Products, Arthur, ON, Canada), consists of two Bacillus
isolates that provide enzymes for assisting digestion,
vitamins and minerals. The Celmanax™ improves milk
production in dairy cattle [17], while the Dairyman’s
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nutritional demands. We monitored the impact of the
feed additives on the current neurological symptoms
that preceded the development of JHS disease, the
occurrence of new neurological symptoms and the
development of new JHS cases.
Dairy production sites 2, 3 and 4 (PS2, PS3, PS4) with no
previous history of JHS
From 2008 to 2010, other dairy production sites in
Southern Alberta were experiencing sudden-onset cattle
deaths, grey-green scours, reduced milk production,
metritis, neurological symptoms (staggering), drooling,
swollen joints and wasting associated with the consump-
tion of mouldy feeds. Jejunal tissues from one animal
per site were sampled. From 6 to 30 mature cattle devel-
oped JHS on each site with an average of 100 lactating
cattle per site. As for PS1, an average of 1 animal per
week had the neurological symptoms that preceded the
JHS losses. The producers applied the prebiotic and pro-
biotic to alleviate the reduc t i o ni nm i l kp r o d u c t i o na n d
we monitored the impact of the feed additives on the
current neurological symptoms, the occurrence of new
neurological symptoms and the development of new
JHS cases.
Dairy production site 5 (PS5) with a history of JHS
A final production site was selected where the veterinar-
ian had annual JHS cases in the herd. No feed additives
were provided to the dairy cattle.
Escherichia coli O157:H7 isolation from PS1-PS5
One cow from PS1 died from complications associated
with a c-section and the tissue served as a negative con-
trol. This animal had no neurological symptoms or
other disease symptoms. One animal from PS2 and PS3
died from complications associated with leucosis and
reproduction respectively. These animals served as nega-
tive controls and did not have any neurological symp-
toms. The tissue from 11 cattle confirmed the JHS
status on PS1 based on the presence of acute hemorrha-
ging in the jejunum, blood clots in the small intestine
and the lack of similar pathology in the control animals.
To compare pathology associated with JHS diagnosis at
multiple production sites, tissue samples were collected
from PS1-PS4 and the pathology recorded. Finally, a
sample was obtained from another veterinary practice
(PS5) with a production site that had a history of JHS to
determine whether there were any obvious differences
in the gross pathology compared to PS1 to PS4. For all
production sites, a 30 to 60 cm piece of tissue was
removed from the acute hemorrhaged region of the jeju-
num within 4 hours after death and transported back to
the laboratory at 4°C. The bloody digesta and clot were
separated into sample tubes and serial dilutions were
plated on Sorbitol MacConkey agar (SMAC; Dalynn
Biologicals, Calgary, Alberta, Canada) to identify non-
sorbitol fermenting bacterial colonies and on Potato
Dextrose agar (PDA; Dalynn Biologicals, Calgary,
Alberta, Canada) to isolate fungi. Adherent or tissue-
colonizing bacteria were collected from the hemor-
rhaged regions. Each tissue was cut open, washed in
cold PBS and 2.5 cm
2 pieces cut out. Care was taken
while cutting not to press down on the tissue and dis-
tort size. Each 2.5 cm
2 intact tissue was incubated with
0.1% Triton X-100 overnight and plated on SMAC agar
to determine the presence of non-sorbitol fermenting
bacterial colonies. Any suspect colonies were tested as
O157 and H7 using the RIM™ E. coli O157:H7 Latex
test (Fisher Scientific, Ottawa, Ontario, Canada). To elu-
cidate whether STEC virulence determinants were criti-
cal to the development of JHS, the blood clot that
blocked the hemorrhaged jejunum and the E. coli O157:
H7 isolates from the hemorrhaged regions were exam-
ined for Stx1 and Stx2 expression using the Meridian
ImmunoCard STAT!
® EHEC test (Somagen, Edmonton,
Alberta, Canada). The Meridian ImmunoCard STAT!
®
EHEC test was optimized for use with cattle samples as
follows: three-day old colonies on SMAC plates were
used in the agar plate method, polymyxin B at 100 μg/
ml, a longer Polymyxin B incubation period (45 min)
and a 300 μl sample was applied to the test well. For
the detection of Stx1 and Stx2 in the blood clot, a 1 ml
volume of the blood was diluted in half with PBS and
300 ul was then applied to the test well.
PCR assay targeting O157 STEC and non-O157 STEC
genes
Initial isolates were chosen from PS1-PS5 for additional
PCR testing based upon their latex agglutination
responses. The PS1, PS3 and PS4 isolates produced
strong agglutination for both O157 and H7 in the
RIM™ E. coli O157:H7 Latex test. One isolate repre-
s e n t i n gt h i sg r o u pw a st e s t e d for identity. The isolates
from the remaining sites produced weak agglutination
with O157 and none to strong agglutination with H7 in
the RIM™ E. coli O157:H7 Latex test. One isolate
representing this group was tested for identity. The pre-
sumptive E. coli O157:H7 colonies were subjected to an
E. coli O157:H7-specific PCR assay targeting the fliC,
eaeA,a n dv e r o t o x i n( vt; VT1 and VT2) genes [18]. In
this assay, vt, eaeA and fliC PCR products are produced
for E. coli O157:H7 strains while, vt PCR products are
produced for non-O157 STEC strains.
DNA microarray assay targeting pathogenic E. coli genes
To further characterize the composition of the infec-
tions associated with JHS cases, isolates were re-
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genes. To select isolates, the samples were transferred to
SMAC, CT-SMAC and CHROMagar™ O157 and two
to five STEC colonies were further characterized based
upon differences in morphology and/or Stx production.
DNA microarrays
The microarray (MaxiVir1.0) used in this study was based
on earlier published work [19] and carries 514 oligonu-
cleotides of 70 bases in length targeting 348 virulence or
virulence-related genes and 96 antimicrobial resistance or
antimicrobial resistance-related genes found in gram-
negative bacteria. The microarray, designed to detect a
complete set of virulence genes representative of all
E. coli pathotypes, includes virulence factors such as
adhesins, locus of enterocyte effacement, colicins and
microcins, toxins, iron acquisition and transport systems,
capsular and somatic antigens, hemolysins and hemaglu-
tinins, as well as newly recognized or putative E. coli
virulence genes. Antimicrobial resistance genes included
in the microarray represent different antimicrobial
families such as b-lactams, aminoglycosides, tetracycline,
phenicols, trimethoprim, sulfonamide and class I inte-
gron. The microarray also carries five positive oligonu-
cleotide controls for E. coli derived from the sequences of
genes encoding tryptophanase (tnaA), beta-glucuronidase
(uidA), lactose permease (lacY), beta-galactosidase (lacZ),
and glutamate decarboxylase (gad). Negative controls
added to this microarray consist of oligonucleotides
derived from the gene sequences for the green fluores-
cent protein of Aequorea victoria, the lactose permease of
Citrobacter freundii, and the chlorophyll synthase from
Arabidopsisthaliana.
Escherichia coli DNA labeling
Bacterial DNA was labeled using Bioprime DNA label-
ing system (Invitrogen Life Technologies, Burlington,
ON, Canada). Fifteen μl of the supernatant containing
DNA was added to a final volume of 32.5 μlc o n t a i n i n g
10 μl of a random primer solution, 0.5 μlo fh i g h - c o n -
centration DNA polymerase (Klenow fragment, 40 U/
μl), 5 μl of a deoxyribonucleosidetriphosphate (dNTP)
mixture (1.2 mM dATP, 1.2 mM dGTP, 1.2 mM dTTP,
and 0.6 mM dCTP in 10 mM Tris [pH 8.0] and 1 mM
EDTA), and 2 μl of 1 mMCy5-dCTP. Labeling reactions
were performed in the dark at 37°C for 3.5 h and
stopped by the addition of 5 μlN a 2EDTA 0.5 M
(pH 8.0). The labeled samples were then purified with a
PureLink PCR purification kit (Invitrogen Life Technol-
ogies, Carlsbad, CA) according to the manufacturer’s
protocol. The amount of incorporated fluorescent Cy5
dye was then quantified by scanning the DNA sample
with a NanoDrop ND-1000 spectrophotometer from
200 to 700 nm. Data were analyzed using a Web-based
percent incorporation calculator http://www.pangloss.
com/seidel/Protocols/percent_inc.html.
Hybridization of labeled DNA
Microarrays were prehybridized at 50°C for 1 hour under a
Lifterslip (25 × 60 mm; Erie Scientific Company, Ports-
mouth, NH, USA) using a SlideBooster hybridization
workstation (model SB800; Advalytix, Germany), with
50 μl of prewarmed (37°C) digoxigenin (DIG) Easy Hyb
Buffer (Roche Diagnostics, Laval, Quebec, Canada) supple-
mented with 5% (vol/vol) bovine serum albumin (1 mg/
ml; New England Biolabs Inc., Beverly, MA). After pre-
hybridization, the lifterslipw a sr e m o v e db yd i p p i n gt h e
slides in 0.1 × SSC (saline-sodium citrate) and were air-
dried. Before hybridization, the samples were dried and
resuspended in 15 μl of hybridization buffer (DIG + 0.1
ug/ul ssDNA) and denatured for five minutes at 95°C.
One microgram of labeled genomic DNA was hybridized
on the MaxiVir1.0 microarray under a lifterslip (18 × 18
mm). The hybridization was carried out overnight at 50°C
in a SlideBooster hybridization workstation. After hybridi-
zation, lifterslips were removed by dipping the slides in a
0.1 × SSC and 0.1% SDS (sodium dodecyl sulfate) solution.
Post-hybridization washes were performed at 37°C: two
washes with 0.1 × SSC and 0.1% SDS for ten and five min-
utes respectively and one last wash in 0.1 × SSC for five
minutes. The microarrays were then air-dried.
Microarray slides were scanned at 5 μmr e s o l u t i o n
with a ScanArray Lite fluorescent microarray analysis
system (Perkin-Elmer, Missasauga, Ontario, Canada).
Acquisition of fluorescent spots was performed using
the ScanArray Express software (Perkin-Elmer, Foster
City, CA). Fluorescent spot intensities were quantified
with ImaGene software version 8.0 (BioDiscovery, Inc.,
El Segundo, CA). All the microarrays were normalized
using the same method. For each subarray, the mean
value for each set of duplicate spotted oligonucleotides
was divided by the correction factor taken from the
negative controls spots. This value was then divided by
the average of the empty spots to create a signal-to-
noise ratio. Oligonucleotide spots with a signal-to-noise
fluorescence ratio greater than the established threshold
(3 in this case), were considered positive. These ratios
were then converted into binary data where a value of
0 indicates a negative probe and a value of 1 a positive
probe. A threshold of 3 was chosen because it best
represented spot quantification. To verify that the
results were accurate, we compared the .bmp image of a
given sample and the quantified result.
Isolation of pathogens from hemorrhaged
tissue in dairy cattle
Washed tissue samples (2.5 cm
2) were placed in 0.1%
TritonX-100 overnight and the released bacteria stored
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digesta was also stored at -80°C or serial dilutions were
direct plated. A 1 to 50 μl aliquot of a diluted sample
was applied to CHROMagar™ Salmonella, CHROMa-
gar™ E. coli, CHROMagar™ O157, CHROMagar™ Sal-
monella Plus, and CHROMagar™ Listeria plates
(Dalynn Biologicals, Calgary, Alberta). To confirm iden-
tity, the presumptive isolates with the exception of the
Listeria were subjected to a GN-ID A + B biochemical
test (Alere™ Canada, Ottawa, Ontario). Presumptive
Salmonella were also subjected to a Salmonella Latex
Agglutination test (Alere™ C a n a d a ,O t t a w a ,O n t a r i o ,
Canada). Presumptive Listeria was identified using a Lis-
teria ID test (Alere™ C a n a d a ,O t t a w a ,O n t a r i o ) .T o
detect Clostridium perfringens type A, samples were
examined for characteristic features using a compound
Nikon microscope set at 1000 × magnification. Digesta
a n dt i s s u es m e a r sw e r ee x a m i n e df o rt h ep r e s e n c eo f
large, rectangular bacilli (rod) with or without spores
(ovoid, sub-terminal). Sub-cultures on blood agar were
examined for rapid spreading growth.
Isolation and identification of mycotoxigenic fungi
Feed components were collected from PS1-PS5. A 10 g
sub-sample of corn silage, barley silage or hay was finely
ground and a 5 ml volume added to a PDA plate. The
plate was incubated for 1 to 7 days and individual fungal
isolates transferred to new PDA plates. Fusarium iso-
lates were identified by examination of micro-morpholo-
gical characters according to Nelson et al. [20] and by
PCR amplification and sequencing of a fragment of the
EF1-a gene and comparing the sequence with the
FUSARIUM-ID database [21]. Penicillium isolates were
identified by microscopic examination of morphology
using the guide by Pitt [22]. Aspergillus species were
identified by microscopic examination of morphology
using the guide provided by Klich [23].
Extraction of cytotoxins from mouldy feed
The methods used have been described previously [24].
The corn silage was almost entirely moldy having a dark
burgundy-red coloration for PS1 and visible pockets of
white to blue mould were present in the barley silage. The
barley silage had visible pockets of white and blue mold
for PS2-PS5, while the hay had a pink coloration for PS3
and PS4. To extract the silages and hay, each sample was
ground, a 25 ml aliquot of 50% ethanol or methanol was
added to a 3 g sample of ground material and placed on a
shaker at 200 rpm for 3 h. The supernatant was collected
in another tube, and stored at 4°C until use.
Mycotoxin analysis
The co-occurrence of mouldy feed and a high number
of JHS cases suggested that a field survey of local corn
crops was warranted for mycotoxin analysis. Cornfields
from PS1 and the surrounding region in Lethbridge
County were selected to compare mycotoxin profiles. A
minimum of 20 intact cobs were collected from each
field, the kernels removed, bagged and sent for commer-
cial analysis (Animal Health Laboratory, University of
Guelph, ON, Canada). The samples from PS1 were also
submitted for analysis to Charm Sciences, Inc. who did
the analysis without charge (Lawrence, MA USA).
Escherichia coli O157:H7 strain and culture conditions
Escherichia coli O157:H7 E318N is a human isolate
(PT14) that was supplied by A. Borezyk, Enteric Refer-
ence Laboratory, Ministry of Health, Toronto, Ontario.
The strain was maintained at -80°C in 25% glycerol: 75%
Luria-Bertoli (LB) broth (Sigma-Aldrich, Oakville,
Ontario, Canada) and was grown statically overnight at
37°C in LB broth (Fisher Scientific, Ottawa, Ontario,
Canada) when required. The strain was serially diluted
to the desired concentration with phosphate-buffered
saline (PBS). Bacterial cell counts were determined by
plating on SMAC agar and examined for non-sorbitol
fermenting colonies that appeared as colorless colonies.
In vitro organ culture (IVOC) E. coli O157:H7 adherence
assay
Healthy necropsy jejunal samples were obtained from
steers using standard methods [4]. Briefly, jejunal tissues
(30 cm) were removed within 2 min of release of the
intestinal tract from the carcass and each piece was
maintained at 4°C for transport back to the laboratory.
Upon arrival, the tissue was cut open, washed using PBS
at 4°C and 2.5 cm
2 pieces were excised. The IVOC
a d h e r e n c ea s s a yw a sc o n d u c t e da sp r e v i o u s l yd e s c r i b e d
[4] using the E. coli O157:H7 E318N strain. This assay
has been established as representing E. coli O157:H7
colonization in vivo and as a useful model system for E.
coli O157:H7 colonization in cattle. To compare the
ability of varying concentrations of the prebiotic, Celma-
nax™,t oi n t e r f e r ew i t hE. coli O157:H7 colonization of
cattle intestinal tissue, 10
7 CFU/ml of E. coli O157:H7
was applied to the mucosal surface of tissue pieces to
which 0%, 0.01%, 0.1%, 1% and 10% Celmanax™ diluted
in DMEM was previously applied. Similarly, 0%, 0.01%,
0.1%, 1% and 10% Dairyman’s Choice™ paste was added
to cell monolayers and 10
7 CFU/ml of E. coli O157:H7
was applied to the mucosal surface. The treated mucosal
explants were incubated for 4 h under standard culture
conditions (37°C, 95% humidity and 5% CO2). After
incubation, each tissue was washed six times with PBS
to remove any unattached bacteria. The tissue was then
turned mucosa-side down in 3 ml of PBS supplemented
with 1% Triton X-100 (Sigma-Aldrich, Oakville, Ontario,
Canada) and incubated at 4°C overnight. After 24 hr,
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SMAC agar and the number of non-sorbitol fermenting
colorless colonies recorded. The Triton X-100 effectively
removed all the attached bacteria after 24 hr incubation
at 4°C. The assay was replicated three times using the
jejunum from three different animals.
In vitro cell culture (IVCC) E. coli O157:H7 E318N
adherence assay
The methodology was described previously for compar-
ing the colonization potential of E. coli O157:H7 strains
belonging to different lineages [25]. Briefly, the cell line
was cultured in DMEM supplemented with 10% fetal
bovine serum (Fisher Scientific, Oakville, Ontario,
Canada) and gentamicin (Sigma-Aldrich, Oakville,
Ontario Canada) under standard culture conditions.
Cells were sub-cultured by trypsinization of the cell
monolayer with 0.25% trypsin-EDTA solution (Sigma-
Aldrich, Oakville, Ontario, Canada) for 5 min at 37°C,
and the supernatant centrifuged at 2 087 × g for 10
min. The cell pellet was re-suspended in the culture
medium and then, added to each well of a 6-well multi-
well Falcon plate (Fisher Scientific, Oakville, Ontario,
C a n a d a )a tad e n s i t yo fa p p r o x i m a t e l y1 0
3 cells. The
cells were grown until they formed a confluent mono-
layer consisting of 10
5 cells.
To determine the impact of the feed additives on
E. coli O157:H7 E318N colonization of the colonic cell
line, each well of confluent cells was washed once with
PBS and then, 3 ml of DMEM with varying concentra-
tions of the prebiotic, Celmanax™,o rp r o b i o t i c ,D a i r y -
man’sc h o i c e ™ paste, including 0%, 0.01%, 0.05% and
0.1%, was added. The concentrations of Celmanax™
used reflected the percentage achievable under stan-
dard feeding regiments for the prebiotics and probio-
tics given the dilution factor of the rumen and the
passage rate for materials in the gastrointestinal tract.
For the IVCC bioassay, we did not exceed 0.1% prebio-
tic or probiotic as it shifted the pH of the media and
affected the health of the cells. Escherichia coli O157:
H7 E318N was added to the cell monolayer to deliver a
final exposure dose of 10
6 CFU/10
5 cells. The cell cul-
tures were incubated for 3 h under standard culture
conditions. At the end of the experiment, cell-mono-
layers were washed with PBS to remove any unattached
bacteria and 2 ml of PBS supplemented with 0.1% Tri-
ton X-100 was added and incubated overnight at 4°C.
Serial dilutions of the released bacteria were performed
and quantified by plating onto SMAC plates. Plates
were incubated at 37°C overnight and E. coli O157:H7
was quantified by counting the non-sorbitol fermenting
colonies that appear colorless. The IVCC assay was
replicated 6 times with a minimum of 3 different
culture dates for the cell line.
Lawn assay for cytotoxicity associated with mouldy feed
extracts and pure mycotoxins
The lawn assay has been described previously [25] and
was used to examine the cytotoxicity of feed extracts
and mycotoxins in the absence and presence of 0.1%
Celmanax™ and Dairyman’sC h o i c e ™ Paste. For the
silage extracts, enterocytes isolated from the jejunum
served as the cell lawn and the silage extracts were
applied to assess for cytotoxicity. Briefly, a 1% SeaKem
®
Agarose (Mandel Scientific, Guelph, Ontario, Canada)
support gel was poured into a petri dish. Next, the lawn
agarose [3 ml of 3.7% SeaPlaque
® agarose (Mandel
Scientific, Guelph, ON, Canada)] was mixed with 3 ml
of cell suspension and poured over the support agarose.
For the pure mycotoxins, cell monolayers were prepared
as described for the IVCC bioassay. A 400 μl aliquot of
0.4% SeaPlaque
® agarose was poured over the cell
monolayer and cooled for 15 min. The mycotoxins
tested included DON (100 μg/ml), ZEAR (100 μg/ml),
T-2 (100 μg/ml), and fumonisin B1 (50 μg/ml; Romer
L a b s ,U n i o n ,M O ,U S A ) .A5μla l i q u o to ft h es t o c k
mycotoxins was applied to the center of each cell mono-
layer. A 5 ul aliquot of the solvent used for the extrac-
tion process and the mycotoxin buffer served as
negative controls. Each extract or mycotoxin (5 μl) was
applied with or without 0.1% prebiotic or probiotic and
the plate incubated for 4 h under standard culture con-
ditions. The lawn was stained with 0.1% trypan blue
(Sigma-Aldrich) and de-stained using PBS. Plates were
scored the same day and the amount of extract cytotoxi-
city was scored as low (1), moderate (2) or high (3)
which was visualized as a faint blue spot, a blue spot or
a dark blue spot respectively. These activities were com-
pared to two standards, ground corn containing 0.1
ppm aflatoxin that had a cytotoxicity score of 1 and 1
ppm aflatoxin that had a cytotoxicity score of 3. The
assay was repeated a minimum of three times.
Data analysis
The IVOC adherence assay and IVCC adherence assay
data were log transformed to normalize the data prior
to analysis. All data were analyzed using ANOVA fol-
lowed by a posthoc Tukey’s test for comparison of the
means. For the IVOC and IVCC data, the model con-
sisted of two factors, passage number of the cell line or
animal and dose. Results were considered significant if P
< 0.05 and non-significant if P > 0.05.
Results
Impact of a prebiotic and probiotic on the symptoms and
development of JHS for PS1
The inclusion of Celmanax™ in the total mixed ration was
associated with both a cessation of current neurological
symptoms and no further development of neurological
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nax™ and Dairyman’sC h o i c e ™ paste for freshening cattle
changed the pattern for JHS development from 1 to 3 ani-
mals per week to 0 animals per week. This pattern was
maintained throughout the winter while the cattle con-
sumed the remaining mouldy corn and barley silage.
Impact of a prebiotic and probiotic on the symptoms and
development of JHS for PS2-4
The inclusion of Celmanax™ and Dairyman’sC h o i c e ™
in the total mixed ration was associated with both a ces-
sation of the current neurological symptoms and no
further development of neurological symptoms in the
lactating cattle. The inclusion of Celmanax™ and Dairy-
man’sC h o i c e ™paste for freshening cattle changed the
pattern for JHS development from 1 animal per week to
0 animals per week. This pattern was maintained
throughout the winter while the cattle consumed the
remaining mouldy barley silage and/or hay.
Pathology associated with the jejunum PS1-PS5
Each tissue was examined and the pathology recorded.
The control tissues had no pathology present. All
hemorrhaged jejunum samples from JHS cases had the
following common pathology: inflamed and raised
Peyer’s Patches in the jejunum, severe jejunal hemor-
rhages visible through the serosa, bloody digesta visible
through the serosa, complete loss of mucosal structure
in the hemorrhaged regions, dark-red erythema, large
blood clots and edema. The main difference between
PS5 and PS1-PS4 was the presence of a much larger
blood clot that completely blocked the passage of
digesta in the jejunum.
Shiga toxin - producing E. coli in the jejunum of cattle
from PS1-PS4 with no history of JHS
Adherent non-sorbitol fermenting colonies were identi-
fied at significant levels colonizing the hemorrhaged
regions of the jejunum relative to the control animals (P
= 0.001, Table 1). There were significantly higher
amounts of non-sorbitol fermenting colonies identified
in the digesta of the jejunum relative to control animals
(P = 0.001, Table 1). There were also sorbitol-ferment-
ing colonies that represented about 50% of the CFU/
sample/site but we did not initially suspect them as
non-O157 STECs. The bacterial isolates were confirmed
as O157 and H7 using the RIM™ E. coli O157:H7 Latex
test, however there was variation in the strength of the
agglutination particularly for O157. All isolates were
examined for the expression of Stx, as this is a key viru-
lence trait associated with more severe forms of animal
disease. All isolates produced Stx1 and Stx2. The consis-
tent presence of significant numbers of STEC in the
hemorrhaged regions for cattle with JHS regardless of
the production site, suggests that the STEC warrant
further investigation as causative agents.
Escherichia coli O157:H7 and Stx in the jejunum of a cow
from PS5 with a history of JHS cases
Adherent non-sorbitol fermenting colonies were identi-
fied at significant levels in the hemorrhaged regions of
the jejunum. This animal had similar amounts of E. coli
O157:H7 present as observed for the other production
sites: 7 × 10
5 CFU/2.5 cm
2 hemorrhaged jejunum, 1.6 ×
10
4 CFU/ml bloody digesta, 6.0 × 10
4 CFU/2.5 cm
2
intact severe focal hemorrhage, 1.7 × 10
5 CFU/2 cm
2
jejunal Peyer’s patch, 2.3 × 10
6 CFU/2.5 cm
2 inflamed
jejunum. To confirm a potential role for Stx in the
development of JHS pathology, we evaluated the isolate
for Stx expression and the blood clot blocking the
hemorrhaged jejunum for the presence of Stx. The iso-
late did express Stx1 and Stx2, but more significantly,
both toxins were detected in the blood clot.
Isolation of pathogens from dairy cattle with JHS
Bacterial pathogens in the digesta and hemorrhaged
mucosa were isolated from the jejunum. CHROMagar™
is a selective media used for presumptive identification
of specific pathogens including Salmonella, E. coli,
E. coli O157 and Listeria[26-28]. Presumptive E. coli
O157 were identified and appeared as regular mauve
colonies (O157 STEC and non-O157 STEC), irregular
mauve colonies or navy blue colonies with a small to
large mauve halo (non-O157 STEC) on CHROMagar™
O157 plates. Presumptive E. coli O157 were confirmed
as pathogenic E. coli in the GNID A + B test. Other pre-
sumptive pathogenic E. coli appeared as blue colonies
on CHROMagar™ E. coli plates. All E. coli were con-
firmed as non-pathogenic E. coli in the GNID A + B
test. White colonies were also found on this medium
that were mauve on CHROMagar™ E. coli O157 and
were identified as pathogenic E. coli in the GNID A + B
Table 1 Average number of STEC CFU per tissue type for dairy cattle with or without JHS
Sample type Cattle with JHS (n = 12)
Mean Log CFU + SE
Cattle without JHS (n = 3)
Mean Log CFU + SE
Jejunum (per 2.5 cm
2 mucosa)
1 5.303 ± 0.184a 0.000 + 0.000b
Digesta (per ml) 4.487 ± 0.172a 0.000 + 0.000b
1 row numbers followed by different letters are significantly different P = 0.001.
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the CHROMagar™ E. coli O157 and for the non-sorbi-
t o lo rs o r b i t o lf e r m e n t i n gc o l o n i e s .P r e s u m p t i v eSalmo-
nella were identified and appeared as mauve colonies on
CHROMagar™ Salmonella plus plates, but were subse-
quently determined as false positives (pathogenic E. coli
using the GNID A+ B kit and the Salmonella Latex
Agglutination kit). Presumptive Listeria species were
identified and appeared as pinpoint blue colonies with a
halo on CHROMagar™ Listeria plates and these isolates
were later determined to be Listeria grayi,an o n - p a t h o -
genic strain. No Clostridiumperfringens type A was
detected. Thus, the only pathogen identified in the
hemorrhaged tissues or bloody digesta for cattle with
JHS regardless of the production site, were STECs.
PCR assay targeting O157 STEC and non-O157 STEC
The variation in the strength of the latex agglutination
test and the possible identification of potential sorbitol-
fermenting STEC suggested that closely related STECs
were present in the tissues rather than E. coli O157:H7
alone. To confirm that not all isolates were E. coli
O157:H7, PCR products produced from each isolate
were characterized. The vt, eaeA and fliC PCR products
were detected for isolates giving strong latex agglutina-
tion for O157 and H7 in the RIM™ E. coli O157:H7
Latex test defining the isolates from PS1, PS3 and PS5
as E. coli O157:H7. In contrast, only vt PCR products
were detected for isolates giving weak latex agglutination
for O157 and H7 in the RIM™ E. coli O157:H7 Latex
test defining the isolates from PS2 and PS4 as non-
O157 STECs.
DNA microarray assay targeting E. coli genes
The results from the bacterial isolations from the
SMAC, CT-SMAC and CHROMagar™ O157 plates
suggested that the tissues had multiple types of STEC
present. There were several distinct morphologies on
the CHROMagar™ O157 plates: mauve colonies with a
circular form, raised elevation and entire or undulate
margin; blue colonies with a mauve halo that had a cir-
cular form, raised elevation and an entire or undulate
margin. These colonies were sorbitol or non-sorbitol-
fermenting and tellurite-resistant. Two common STEC
morphologies were observed in all tissues: regular
mauve colonies having a circular form, raised elevation
and entire margin; blue colonies with a mauve halo hav-
ing a circular form, raised elevation and entire margin.
T h eD N Am i c r o a r r a ya s s a yc o n f i r m e dt h a tm i x t u r e so f
non-O157 STEC were colonizing the hemorrhaged tis-
sues and these isolates have the locus of enterocyte effa-
cement (LEE) pathogenicity island, stx1A, stx1B and
hlyA. Finally, in addition to the genes mentioned above,
variability in the presence of other virulence genes also
supports the notion of a mixed STEC population. Inter-
estingly, the absence of the stx2 gene in all the charac-
terized isolates suggests that the detected Stx2 from the
isolate and blood samples may represent a strain that
was not ultimately isolated.
Mycotoxigenic fungi in silages for the production sites
Unlike previous reports for JHS, there was no A. fumi-
gatus present in the silage samples from PS1 (Table 2).
There were several types of mycotoxigenic fungi present
in the corn silage including F. culmorum, A. flavus,
P. roqueforti, P. crustosum, P. paneum and P. citrinum.
There were several fungi present in the barley silage
including F. poae, F. verticillioides, F. sporotrichioides,
P. roqueforti, P. citrinum and A. flavus (Table 2). We
also identified several fungi in the hemorrhaged regions
from the dairy cattle with JHS including P. roqueforti,
Trichothecium roseum, A. flavus and P. citrinum.F o r
PS2-PS4, there was no A. fumigatus present in the bar-
ley silage or hay. There were several fungi present in the
barley silage including F. poae, F. verticillioides, F. sporo-
trichioides, P. roqueforti, P. citrinum and A. flavus
(T a b l e2 ) .T h e r ew e r ef e w e rf u n g ip r e s e n ti nt h eh a y
including F. poae, P. roqueforti, P. crustosum and
P. paneum.T h eFusarium species were present in the
hemorrhaged regions from the dairy cattle with JHS.
Mycotoxin Analysis
There were no mycotoxins detected for the corn silage
in PS1 using the ROSA
® Fumonisin test, ROSA
® Afla-
toxin test, ROSA
® Zear test or ROSA
® Don test. The
samples were categorized as very dirty which could
result in matrix interference or be difficult to analyze
using standard commercial methods. There were several
mycotoxins detected using commercial HPLC methods
for the corn from eight fields in Lethbridge County
including PS1 (Table 3). Because the bloody gut symp-
toms suggested that fumonisin or T-2 toxin could be
Table 2 Percent of samples positive for mycotoxigenic
fungi for each corn silage, barley silage and hay sample
from production sites (n = 5-10)
Mycotoxigenic Fungi Corn Silage Barley Silage Hay
Fusarium culmorum 100 0 0
F. poae 0 100 100
F. verticillioides 0 100 0
F. sporotrichioides 0 100 0
Aspergillusflavus 100 20 0
Penicillium roqueforti 100 100 100
P. crustosum 20 0 20
P. paneum 20 0 20
P. citrinum 50 25 0
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formed using LC/MS/MS. The fumonisin B1 levels were
very high for PS1 and one other field that was part of a
commercial business providing corn to producers for
silage production.
IVOC E. coli O157:H7 adherence assay
The Dairyman’sC h o i c e ™ paste had no effect on E. coli
O157:H7 colonization of the mucosal explants in vitro
(data not shown). There was a significant dose-depen-
dent reduction in E. coli O 1 5 7 : H 7c o l o n i z a t i o no ft h e
mucosal explants from the jejunum in response to vary-
ing concentrations of Celmanax™ (P = 0.001, Figure 1).
The threshold dose for the reduction in E. coli O157:H7
colonization of the mucosal explants was 0.01% Celma-
nax™ when compared with the control (P =0 . 0 0 1 ,
Figure 1). This resulted in about a 10-fold reduction in
colonization per tissue. Thereafter, there was a contin-
ued decline in E.coli O157:H7 colonization with a maxi-
mum effect at 1% Celmanax™ when compared with the
control (P = 0.001, Figure 1). This resulted in about a
100-fold reduction in colonization per tissue.
IVCC E. coli O157:H7 adherence assay
The Dairyman’sC h o i c e ™ paste had no effect on E. coli
O157:H7 colonization of the bovine colonic cell line in
vitro (data not shown). There was a significant dose-
dependent reduction in E. coli O157:H7 colonization of
the bovine colonic cell line in response to varying con-
centrations of Celmanax™ (P =0 . 0 0 1 ,F i g u r e2 ) .T h e r e
was a significant passage effect (p = 0.001) with no pas-
sage/treatment interaction suggesting that Celmanax™
affected pathogen colonization regardless of passage
number. The threshold dose for the reduction in E. coli
O157:H7 colonization of the colonic cell line was 0.01%
Celmanax™ when compared with the control (P = 0.05,
Figure 2). This resulted in about a 1.6-fold reduction in
Table 3 Quantitification of mycotoxins in corn from eight
production sites in Lethbridge County
Mycotoxin ppm
DON 0.06-0.30
15-DON 0.05-0.08
3-ADON 0.05
NEO 0.07
DAS 0.06
HT-2 0.04
T-2 0.06
NIV 0.12
Aflatoxin B1 0.001
Aflatoxin B2 0.0003
Aflatoxin G1 0.002
Aflatoxin G2 0.0005
ZEAR 0.04
Ochratoxin A 0.004-1.5
Fumonisin B1 26-43
Fumonisin B2 5.1-9.4 Figure 1 The impact of varying concentrations of Celmanax™
on Escherichia coli O157:H7 E318N colonization of mucosal
explants from the jejunum (n =3 ) . The 2.5 cm
2 mucosal explant
was exposed to 10
7 CFU (***, P = 0.001).
Figure 2 The impact of varying concentrations of Celmanax™
on Escherichia coli O157:H7 E318N colonization of a colonic
cell line (n = 6-8). A confluent monolayer of a bovine colonic cell
line (10
5 cells) was exposed to 10
5 CFU (*, P = 0.05; ***, P = 0.001).
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5cells. Thereafter, there was a contin-
ued decline in E. coli O157:H7 colonization with a maxi-
mum effect at 0.1% Celmanax™ when compared to the
control (P = 0.001, Figure 2). This resulted in a 2.5-fold
reduction in colonization per 10
5 cells. Higher doses
could not be evaluated as they shifted the pH to favor
acidic conditions. Overall, the colonic cell line provided
similar E. coli O157:H7 colonization responses to the
inclusion of the prebiotic, but at a lower sensitivity
when compared with the IVOC bioassay.
Lawn assay for cytotoxicity associated with feed extracts
and mycotoxins
The 50% methanol and 50% ethanol extracts from feed
components were equally cytotoxic to enterocytes. At
least one or more of the mouldy feed components had
similar cytotoxicity scores regardless of production site
(P > 0.05), as such the data was pooled and it is pre-
sented in Figure 3.
The extracts from the corn silage from PS1 produced
cytotoxicity equivalent to a 1 ppm aflatoxin (in corn)
standard or cytotoxicity score of 3. Equivalent extracts
from the barley silage produced a ten fold lower cyto-
toxicity equivalent to a 0.1 ppm aflatoxin (in corn) stan-
dard or a cytotoxicity score of 1. A 0.1% concentration
of Celmanax™ eliminated the silage extract cytotoxicity
regardless of the extraction buffer or the silage type. A
0.1% concentration of Dairyman’sC h o i c e ™ paste had
no effect on silage extract cytotoxicity (Figure 3, P >
0.05). The 50% methanol extracts of the barley silages
from PS2-PS5 were equally cytotoxic to enterocytes pro-
ducing cytotoxicity equivalent to 1 ppm aflatoxin (in
corn) standard or a cytotoxicity score of 3. However,
PS3 and PS4 also had the same activity associated with
the 50% methanol hay extracts. Similarly, a 0.1% con-
centration of Celmanax™ significantly reduced the
extract cytotoxicity regardless of the extraction buffer or
the feed type (P = 0.001).
The DON, T-2, ZEAR and fumonisin B1 were cyto-
t o x i ct oac o l o n i cc e l ll i n ef r o mc a t t l e( T a b l e4 ) .T h e
cytotoxicity score was equivalent to a 1 ppm aflatoxin
(in corn) standard or an average cytotoxicity score of 2
or 3 depending upon the mycotoxin. A 0.1% concentra-
tion of Celmanax™ significantly reduced the cytotoxi-
city regardless of mycotoxin type (P = 0.001, Table 4).
The cytotoxicity of all feed extracts and mycotoxins
were essentially eliminated by the presence of Celma-
nax™ suggesting that this prebiotic is able to interfere
with the ability of the mycotoxin to interact with the
target cells.
Discussion
JHS is a hemorrhagic disease in dairy cattle with the
main pathology presenting as hemorrhaging, severe
inflammation, mucosal erosion and a major blood clot
blocking the jejunum [5]. Two factors are being investi-
gated as causative agents namely mouldy feeds contain-
ing A. fumigatus and a pathogen C. perfringens type A.
In the current study, we confirmed the presence of
mycotoxigenic fungi but not A. fumigatus in the mouldy
Figure 3 Impact of 0.1% Celmanax™ (C) and Dairyman’s
Choice™ (DC) paste on the cytotoxicity of methanol
extractions from feed (n = 24 for feed extracts, n = 24 for Feed
+ C, n = 6 for Feed + DC; ***, P = 0.001).
Table 4 Impact of 0.1% Celmanax™ and Dairyman’s
Choice™ paste on the cytotoxicity of T-2, DON, ZEAR
and Fumonisin B1, n=3.
Treatment Cytotoxicity Index
1,2 (Mean ± S.E.)
Control (50% methanol) 0 ± 0 a
D O N 3±0b
ZEAR 2 ± 0.6 b
T - 2 3±0b
FUM B1 3 ± 0 b
Celmanax™ +D O N 0±0a
Celmanax™ + Zear 0 ± 0 a
Celmanax™ +T - 2 0±0a
Celmanax™ + FUM B1 0 ± 0 a
Dairyman’s Choice™ +D O N 3±0b
Dairyman’s Choice™ + ZEAR 2 ± 0.6 b
Dairyman’s Choice™ +T - 2 3±0b
Dairyman’s Choice™ + FUM B1 3 ± 0 b
1 0 = no cytotoxicity or no blue spot; 1 = about 25% cell death or faint blue
spot; 2 = about 50% cell death or blue spot; 3 = about 100% cell death or
dark blue spot.
2 column means followed by different letters are significantly different from
each other P < 0.001.
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tion, we further expanded this association to include
mycotoxins in feed components. Specific mycotoxins
such as T-2 toxin do promote gastrointestinal lesions
[29], but they do not induce hemorrhaging on their
own. Since fumonisin B1 was present at significant
levels in the corn crop and it can cause abdominal pain
or diarrhea upon ingestion [30], the pain and abnormal
feces observed in the current study suggest that there
may be an interaction between pathogen colonization,
mycotoxin concentrations and the development of JHS.
In earlier JHS studies targeting the identification of
potential pathogens, C. perfringens type A was detected,
but there was some question as to whether this was
relevant as it is a normal inhabitant of the intestine that
quickly overgrows upon death. In the current study, no
C. perfringens type A was detected but significant O157
STEC and non-O157 STEC were colonizing the hemor-
rhaged mucosa. STECs do cause diarrhea in other ani-
mal model systems [31] and their presence in the
hemorrhaged region merits further investigation. With
the exception of experimental challenge studies with E.
coli O157:H7 [4], these pathogens are not known to
cause disease in mature cattle. However, it is possible
that this class of pathogens has been overlooked as most
of the animals succumbing to JHS do so at production
sites. If STECs are pathogens of cattle, they should
express similar virulence traits described for serious
forms of disease in other animals. One virulence deter-
minant, Stx expression, is critical for the development of
severe disease symptoms in susceptible animals [32-34].
Stxs have both lethal [35-37] and sublethal [38] effects
on cells that benefit pathogen colonization by providing
a foothold in the mucosa for replication and increasing
the availability of non-intimate attachment sites. All of
the STECs isolated from the cattle diagnosed with JHS
expressed Stx and the Stxs were present in the blood
clot that blocked the jejunum suggesting that the STECs
did have the appropriate virulence traits to elicit serious
disease. Future research should focus on examining the
contribution of mycotoxins and STECs to the infection
process associated with JHS.
Cattle supplemented with prebiotics or probiotics show
improvements in performance measurements such as milk
production and feed conversion efficiencies [15,39-42].
Improvements in animal health are limited to observations
of lower incidences of scours in calves [43], improved
immune function in calves [44] or lower somatic cell
counts in cattle [39,45]. Given that both types of products
can alter rumen microbial populations [16,40] and prevent
rumen acidosis [41,42], these benefits have always been
interpreted as an improvement in rumen function. Only a
few animal studies have examined the potential use of pro-
biotics or prebiotics to inhibit enteric pathogens such as
E. coli O157:H7 in the gastrointestinal tract of cattle
[14,15] and as far as we are aware, no cattle tissue or cell
studies have been attempted. In monogastric livestock,
prebiotics directly act as anti-adhesives against E. coli
O157:H7 by mimicking host cell receptor sites [46] and
mucin binding sites [8]. This reduces both the amount of
E. coli O157:H7 colonization and the number of bacteria/
microcolony. In the current study, the absence of an active
immune system in the IVOC or IVCC bioassay together
with the decrease in E. coli O157:H7 colonization in the
presence of Celmanax™ supports an anti-adhesive beha-
vior for the prebiotic. The second benefit of the prebiotic
was that it blocked the cytotoxicity associated with the
silages and the pure mycotoxins in vitro suggesting that it
binds-up the toxic elements in a way that prevents cellular
interactions. In contrast, the Dairyman’sC h o i c e ™ paste
had no such effect in the bioassays. The administration of
the prebiotic or the prebiotic + probiotic to the cattle was
associated with a cessation of neurological symptoms, no
further development of neurological symptoms and no
further development of new JHS cases. Future studies
should examine the mechanisms responsible for the pre-
biotic or prebiotic:probiotic associated reduction in
disease.
Prebiotics are non-digestible mannan oligosaccharides
(MOS) that are used in feed rations of cattle to improve
performance parameters [2]. These products are obtained
from disrupting cell walls of yeast with each product
claiming to have a more effective, ruminant-specific starter
strain or formulation. Other ingredients can also be pre-
sent in prebiotic formulations including d-mannose which
blocks pathogen type-1 pili binding to receptor sites
[6,45], glucomannan which absorbs feed-related toxins
[12,42,46], and a yeast extract that provides a concentrated
B vitamin supplement that can induce innate immune
responses [10,11]. The impact of prebiotics on livestock
performance is variable [44,47,48] suggesting that the type
of oligosaccharide or added ingredients may influence the
measured changes in animal performance. In cattle, to be
effective, prebiotics must navigate through the fermenta-
tion/digestion processes of the upper gastrointestinal tract
prior to interacting with target sites in the intestinal tract.
Therefore, the variation in responsiveness reported in stu-
dies could be related to the persistence of the prebiotic or
additional ingredients in the gastrointestinal tract. The
lower incidence of disease associated with prebiotic use in
cattle [44,45] together with the results of the current study
suggest that a prebiotic, such as Celmanax™, warrant
further investigation as disease management tools.
Escherichia coli pathogens initially adhere to the
mucus layer in the intestinal tract prior to colonization
of target intestinal cells [49]. The IVOC or mucosal
explant bioassay has a mucus layer and target cells
while the IVCC bioassay has cells only. This suggests
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related to the impact of the mucus layer on pathogen
colonization. In addition, the larger reduction associated
with the mucosal explant bioassay suggests a greater
impact than predicted with the cell line bioassay in vivo.
Previous studies with monogastric cell lines have shown
that 1.6% prebiotic (GOS) reduced up to 70% E. coli
pathogen colonization of Caco-2 and Hep-2 cells, while
0.1% prebiotic reduced E. coli pathogen colonization of
Caco-2 cells by 10% [9]. In contrast, 1% Celmanax
™
reduced up to 98% O157 STEC colonization of mucosal
explants and 0.1% Celmanax™ reduced up to 50% E. coli
O157:H7 colonization of the bovine colonic cell line in
vitro. Together, these results suggest that prebiotics could
significantly alter STEC colonization at the mucosa and
the amount of anti-adhesive behavior may be related to
chemical composition. Future studies should characterize
the mode of action of prebiotics to provide the basis for
evaluating them as pathogen mitigation agents.
Conclusion
The current study confirmed that cattle developed JHS
disease after consuming feed containing mycotoxigenic
fungi, but also expands this association to include the
mycotoxins deposited in the feed. Unlike earlier studies,
we did not confirm the presence of C. perfringens type
A. A mixture of novel pathogens was colonizing the
hemorrhaged tissues, O157 STEC and non-O157 STEC.
S h i g at o x i n sw e r ee x p r e s s e db yt h eS T E C sa n dw e r e
present in the blood clot blocking the hemorrhaged jeju-
num. A prebiotic, Celmanax™, acted as an anti-adhesive
agent for STEC colonization and a mycotoxin binder in
vitro. The addition of the prebiotic to alleviate milk pro-
duction losses also was associated with a reduction in
disease. Future studies should examine the extent of the
involvement of the different STECs in the infection pro-
cess that is associated with the development of JHS. In
addition, further characterization of the mode of action
of prebiotics is required to adequately assess them as
disease management tools for cattle.
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